News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Melatonin: An important anticancer agent in colorectal cancer
- Osteosarcoma and acromegaly: a case report and review of the literature
- Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2
- Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide
- Immunoregulatory role of melatonin in cancer
- Vitamin E protects proteins against free radical damage in lipid environments
- Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid
- Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage to bladder tissue in rats
- Melatonin as an organoprotector in the stomach and the pancreas
- Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2
- Association between serum vitamin D levels and gastric cancer: A retrospective chart analysis
- Modifying effect of vitamins C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells
- Expression of somatostatin receptors in peritumoral veins of human tumors
- Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial
- Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy
- The clinical neuroimmunotherapeutic role of melatonin in oncology
- Pineal melatonin, its fundamental immunoregulatory role in aging and cancer
- Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN-238
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- How effective is chemo therapy?
- Frequently Asked Questions
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways